Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PGEN | Common Stock | Award | $69K | +59K | +21.37% | $1.17 | 335K | Mar 9, 2023 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PGEN | Restricted Stock Units | Award | $0 | +107K | $0.00 | 107K | Mar 9, 2023 | Common Stock | 107K | Direct | F2, F3 | ||
transaction | PGEN | Option to Purchase Common Stock (Right to Buy) | Award | $0 | +125K | $0.00 | 125K | Mar 9, 2023 | Common Stock | 125K | $1.17 | Direct |
Id | Content |
---|---|
F1 | The shares were issued to the reporting person in lieu of an annual retainer of $69,000. |
F2 | Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. |
F3 | The RSUs vested in full on March 9, 2024. |